Study identifier:D5242R00005
ClinicalTrials.gov identifier:NCT07446738
EudraCT identifier:N/A
CTIS identifier:N/A
PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Chronic rhinosinusitis with nasal polyps
N/A
No
-
All
146
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Other
Verified 01 Sept 2026 by AstraZeneca
AstraZeneca
-
No locations available
| Arms | Assigned Interventions |
|---|---|
| Other: CRSwNP Registry Cohort This is a prospective, multicenter real-world observational study .Patients will receive standard medical care as determined by the treating physician according to routine clinical practice at each site. No treatment assignment will be made as part of the study. | - |